HOUSTON--(BUSINESS WIRE)--Regenetech, Inc., the tissue regeneration adult stem cell company which has built upon NASA licensed technology, today announced that it has raised approximately $2.5 million via a significant round of equity financing. The financing was completed with Royal Securities Co., a brokerage firm acting in conjunction with Outrider Investors.
